These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 37838521)
1. Impact of the Spanish consensus for improving lipid control on patients admitted for an acute coronary syndrome. Escobar C; Barrios V; Cequier A; Cosin-Sales J; Seijas J; Doblas JJG; Arrarte V; Tuñon J; Banach M; J Clin Lipidol; 2023; 17(6):756-764. PubMed ID: 37838521 [TBL] [Abstract][Full Text] [Related]
2. Clinical reality and challenges with familial hypercholesterolemia patients' management. 2024 results from the Regional Center for Rare Diseases (RCRD) Registry in Poland. Lewek J; Sosnowska B; Starostecka E; Konopka A; Gach A; Rutkowska L; Adach W; Mierczak K; Bielecka-Dąbrowa A; Banach M Int J Cardiol; 2025 Jan; 419():132667. PubMed ID: 39442759 [TBL] [Abstract][Full Text] [Related]
3. Recaticimab as Add-On Therapy to Statins for Nonfamilial Hypercholesterolemia: The Randomized, Phase 3 REMAIN-2 Trial. Sun Y; Lv Q; Guo Y; Wang Z; Huang R; Gao X; Han Y; Yao Z; Zheng M; Luo S; Li Y; Gu X; Zhang Y; Wang J; Hong L; Ma X; Su G; Sheng J; Lai C; Shen A; Wang M; Zhang W; Wu S; Zheng Z; Li J; Zhong T; Wang Y; He L; Du X; Ma CS J Am Coll Cardiol; 2024 Nov; 84(20):2037-2047. PubMed ID: 39505412 [TBL] [Abstract][Full Text] [Related]
4. Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study. Masana L; Zambon A; Schmitt CP; Taylan C; Driemeyer J; Cohen H; Buonuomo PS; Alashwal A; Al-Dubayee M; Kholaif N; Diaz-Diaz JL; Maatouk F; Martinez-Hervas S; Mangal B; Löwe S; Cunningham T Lancet Diabetes Endocrinol; 2024 Dec; 12(12):880-889. PubMed ID: 39426393 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries. Reijman MD; Tromp TR; Hutten BA; Hovingh GK; Blom DJ; Catapano AL; Cuchel M; Dann EJ; Gallo A; Hudgins LC; Raal FJ; Ray KK; Sadiq F; Soran H; Groothoff JW; Wiegman A; Kusters DM; ; Lancet Child Adolesc Health; 2024 Jul; 8(7):491-499. PubMed ID: 38759658 [TBL] [Abstract][Full Text] [Related]
7. Rapid achievement of low-density lipoprotein cholesterol goals within 1 month after acute coronary syndrome during combination therapy with rosuvastatin, ezetimibe and bempedoic acid: Initial experience from the LAI-REACT study. Mahajan K; Puri R; Duell PB; Dutta D; Yadav R; Kumar S; Sharma JB; Patel P; Dsouza S; Gupta A; Khan A; Wong ND J Clin Lipidol; 2024; 18(5):e867-e872. PubMed ID: 39278778 [TBL] [Abstract][Full Text] [Related]
8. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling. Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689 [TBL] [Abstract][Full Text] [Related]
9. Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry. Navar AM; Shah NP; Shrader P; Thomas LE; Ahmad Z; Allred C; Chamberlain AM; Chrischilles EA; Dhalwani N; Effron MB; Hayek S; Jones LK; Kalich B; Shapiro MD; Wójcik C; Peterson ED Am Heart J; 2025 Jan; 279():107-117. PubMed ID: 38972336 [TBL] [Abstract][Full Text] [Related]
10. Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry. D'Erasmo L; Bini S; Casula M; Gazzotti M; Bertolini S; Calandra S; Tarugi P; Averna M; Iannuzzo G; Fortunato G; Catapano AL; Arca M; Eur J Prev Cardiol; 2024 Jun; 31(8):1038-1047. PubMed ID: 38374534 [TBL] [Abstract][Full Text] [Related]
11. The German Lipoprotein Apheresis Registry-Summary of the eleventh annual report. Schettler VJJ; Selke N; Jenke S; Zimmermann T; Schlieper G; Bernhardt W; Heigl F; Grützmacher P; Löhlein I; Klingel R; Hohenstein B; Ramlow W; Vogt A; Julius U; Atherosclerosis; 2024 Nov; 398():118601. PubMed ID: 39342791 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
13. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
14. Prescription Fills Among Patients With Type 2 Diabetes After Hospitalization for Acute Coronary Syndrome. Kelsey MD; Ford C; Oakes M; Soneji S; Bosworth HB; Pagidipati NJ JAMA Netw Open; 2024 Nov; 7(11):e2447102. PubMed ID: 39602121 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial. Vermeire S; Schreiber S; Rubin DT; D'Haens G; Reinisch W; Watanabe M; Mehta R; Roblin X; Beales I; Gietka P; Hibi T; Hospodarskyy I; Ritter T; Genovese MC; Kwon P; Santermans E; Le Brun FO; Barron R; Masior T; Danese S Lancet Gastroenterol Hepatol; 2024 Dec; ():. PubMed ID: 39637881 [TBL] [Abstract][Full Text] [Related]
16. Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial. Chowdary P; Angchaisuksiri P; Apte S; Astermark J; Benson G; Chan AKC; Jiménez Yuste V; Matsushita T; Høgh Nielsen AR; Sathar J; Sutton C; Šaulytė Trakymienė S; Tran H; Villarreal Martinez L; Wheeler AP; Windyga J; Young G; Thaung Zaw JJ; Eichler H Lancet Haematol; 2024 Dec; 11(12):e891-e904. PubMed ID: 39521008 [TBL] [Abstract][Full Text] [Related]
17. Treatment options for patients with pilonidal sinus disease: PITSTOP, a mixed-methods evaluation. Brown S; Hind D; Strong E; Bradburn M; Din FVN; Lee E; Lee MJ; Lund J; Moffatt C; Morton J; Senapati A; Shackley P; Vaughan-Shaw P; Wysocki AP; Callaghan T; Jones H; Wickramasekera N; Health Technol Assess; 2024 Jul; 28(33):1-113. PubMed ID: 39045854 [TBL] [Abstract][Full Text] [Related]
18. Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis. Curry N; Davenport R; Thomas H; Fox E; Lucas J; Evans A; Massou E; Sharma R; Shanmugaranjan S; Rourke C; Newton A; Deary A; Dallas N; Fitzpatrick-Creamer C; Podbielski JM; Wade CE; Edwards A; Benger J; Morris S; Cotton BA; Piercy J; Green L; Brohi K; Stanworth S Health Technol Assess; 2024 Nov; 28(76):1-69. PubMed ID: 39545850 [TBL] [Abstract][Full Text] [Related]
19. Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets. Mihaylova B; Wu R; Zhou J; Williams C; Schlackow I; Emberson J; Reith C; Keech A; Robson J; Parnell R; Armitage J; Gray A; Simes J; Baigent C Health Technol Assess; 2024 Dec; 28(79):1-134. PubMed ID: 39644281 [TBL] [Abstract][Full Text] [Related]